Parkman Healthcare Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.38M	Sell	147,980 -156,264	-51%	-$5.68M	0.62%	58
2025 Q1	$11M	Buy	304,244 +204,085	+204%	+$7.39M	1.31%	28
2024 Q4	$4.21M	Sell	100,159 -9,309	-9%	-$392K	0.56%	49
2024 Q3	$6.08M	Buy	109,468 +9,468	+9%	+$526K	0.78%	44
2024 Q2	$4.11M	Buy	+100,000	New	+$4.11M	0.55%	60